Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by Nailbiter2on Jun 07, 2023 9:55pm
150 Views
Post# 35485677

RE:RE:SEDAR

RE:RE:SEDAR
Nailbiter2 wrote:
Nailbiter2 wrote: The results of the vote for the election of directors are as follows:

JamesHoward-Tripp 75% for 
Rory Riggs 92% for
HarryGlorikian 72% for
Garth MacRae 76% for

Appointment of SRCO Professional Services LLP as auditors of the Company with 96% votes for;

Approval of an ordinary resolution authorizing and approving matters related to private placement transactions pursuant to the capital commitment agreement dated November 17, 2022 between the Corporation and GEM Global Yield LLC SCS with 88% votes for;

and Approval of an ordinary resolution authorizing and approving the issuance of 10,745,077 common shares of the Corporation in connection with the conversion of US$562,065 Notes with 95% for.

Anybody remember what Tripp's numbers were last AGM?
Riggs got a good boost.


James Howard-Tripp 84% for
Rory Riggs 89% for
Harry Glorikian 89% for
Garth MacRae 89% for

<< Previous
Bullboard Posts
Next >>